Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial

ConclusionsLT is safe, feasible, and well-tolerated in people with MS-associated fatigue. Improvement in both light spectra likely indicates a strong placebo effect for the DRLT group.
Source: Journal of Neurology - Category: Neurology Source Type: research